Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Laura M. Wiltsie, D.O.

Concepts (41)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Laura Wiltsie's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Laura Wiltsie has written about over time.
Antibodies, Monoclonal, 1 publications between 2018 and 2018, average publication date March 2018. Antibody Affinity, 1 publications between 2018 and 2018, average publication date March 2018. Cell Membrane, 1 publications between 2018 and 2018, average publication date March 2018. Membrane Microdomains, 1 publications between 2018 and 2018, average publication date March 2018. Ependymoma, 1 publications between 2019 and 2019, average publication date June 2019. Healthcare Disparities, 1 publications between 2019 and 2019, average publication date June 2019. Registries, 1 publications between 2019 and 2019, average publication date June 2019. Granuloma, Plasma Cell, 1 publications between 2021 and 2021, average publication date February 2021. Neoplasms, 2 publications between 2021 and 2023, average publication date March 2022. Amblyopia, 1 publications between 2023 and 2023, average publication date February 2023. Exophthalmos, 1 publications between 2023 and 2023, average publication date February 2023. Neurofibroma, Plexiform, 1 publications between 2023 and 2023, average publication date February 2023. Neurofibromatosis 1, 1 publications between 2023 and 2023, average publication date February 2023.

To see the data from this visualization as text, click here.
Wiltsie's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (41)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.